ArticlePloS one2019

Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.

Silvia M Titan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.